AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care-navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.
Cardio Diagnostics Holdings' AI solutions, Epi+GenCHD and PrecisionCHD, use blood samples to provide patients with personalized information regarding their risk for coronary heart disease based on...